RegentAtlantic Capital’s DaVita DVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-2,584
Closed -$207K 675
2022
Q2
$207K Sell
2,584
-1,164
-31% -$118K 0.01% 635
2022
Q1
$424K Sell
3,748
-46
-1% -$5.16K 0.01% 497
2021
Q4
$432K Sell
3,794
-15
-0.4% -$1.61K 0.01% 480
2021
Q3
$443K Sell
3,809
-11
-0.3% -$1.38K 0.01% 462
2021
Q2
$460K Sell
3,820
-59
-2% -$6.98K 0.01% 448
2021
Q1
$418K Sell
3,879
-184
-5% -$20.4K 0.01% 413
2020
Q4
$477K Buy
4,063
+182
+5% +$18.5K 0.02% 348
2020
Q3
$332K Buy
3,881
+69
+2% +$5.89K 0.01% 380
2020
Q2
$302K Buy
+3,812
New +$298K 0.02% 385
2015
Q1
Sell
-1,340
Closed -$101K 505
2014
Q4
$101K Buy
+1,340
New +$101K 0.01% 451

Other funds holding DVA

RegentAtlantic Capital's DVA Position: Q3 2022 in Review

RegentAtlantic Capital sold out of DaVita (DVA) in Q3 2022, closing a stake of 2,584 shares — an estimated $207K sold.

RegentAtlantic Capital first reported a position in DVA in Q4 2014 and held it in 10 quarters. The position peaked at $477K in Q4 2020. 442 funds tracked by Wall St. Rank hold DVA as of Q3 2022.

  • RegentAtlantic Capital reported no remaining DaVita position as of Q3 2022 after selling out during the quarter.
  • RegentAtlantic Capital sold 2,584 DaVita shares in Q3 2022, an estimated $207K.
  • RegentAtlantic Capital first reported a position in DaVita in Q4 2014 and held it in 10 quarters.
  • RegentAtlantic Capital's DaVita position peaked at $477K in Q4 2020.
  • 442 funds tracked by Wall St. Rank held DaVita as of Q3 2022.

Based on RegentAtlantic Capital's 13F filing for Q3 2022, filed 14 Nov 2022.